Weekly Spotlight - 14.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Myositis Autoantibodies: Key Insights into Disease Pathogenesis

The article highlights the significance of myositis-specific autoantibodies (MSAs) in diagnosing and understanding idiopathic inflammatory myopathies (IIMs). MSAs, alongside autoreactive T cells, play a crucial role in the disease's pathogenesis. This review offers updated insights from clinical and translational studies, fostering hope for improved patient outcomes.

CAR-T Therapy Shows Promise for Myositis Treatment in Early Trials

Cabaletta Bio's CAR-T therapy shows promise for treating myositis, with early trials indicating safety and clinical improvement. CABA-201 aims to reset the immune system, potentially offering long-term remission. While results are encouraging, further research is needed. The therapy could address unmet needs in autoimmune diseases, providing hope for patients.

Psychoeducational Intervention Enhances Myositis Patients' Quality of Life and Well-being

The study highlights a psychoeducational programme's positive impact on myositis patients' quality of life and well-being. Through five sessions, patients experienced improved self-efficacy and social relationships. Although the sample size was small, the findings suggest that targeted interventions can significantly enhance life experiences for those with myositis.

Herbal Supplements Risky for Autoimmune Skin Conditions

Immunostimulatory herbal supplements can worsen autoimmune skin diseases like dermatomyositis. A study found that these supplements, including spirulina and elderberry, often lead to disease flares. Patients, especially younger ones, mistakenly believe in their benefits. Education helps them understand risks and discontinue use, promoting better health management.